This Congolese Doctor Discovered Ebola But Never Got Credit For It — Until Now

Dr. Jean-Jacques Muyembe first confronted a mysterious, bloody disease in 1976. But credit for the discovery went to Belgian researchers.(Image credit: Samantha Reinders for NPR)
Source: NPR Health and Science - Category: Consumer Health News Authors: Source Type: news

Related Links:

Source: BMJ News - Category: General Medicine Source Type: research
[VOA] This week the European Commission gave approval to a Ebola vaccine -- an act that the World Health Organization calls landmark moment for global health and a likely game-changer in the battle against this deadly disease.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
U.S. drugmaker Merck&Co Inc on Monday received approval from the European Commission to market its Ebola vaccine, less than a month after a European medicines panel backed the first-ever vaccine against the deadly virus.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
A recap of Tuesday’s top stories: Pneumonia number one killer of children; Australia’s wildfires rage on; Ebola vaccine gets green light; new child labour and trafficking study; Malnutrition soars in Latin America and Caribbean; Intellectual Property chief encourages innovation.
Source: UN News Centre - Health, Poverty, Food Security - Category: International Medicine & Public Health Source Type: news
U.S. drugmaker Merck &Co Inc on Monday received approval from the European Commission to market its Ebola vaccine.
Source: CBC | Health - Category: Consumer Health News Tags: News/Health Source Type: news
In big global health news, the European Commission has granted Merck Sharp and Dohme B.V. marketing authorization in Europe for Ervebo.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news
Nature, Published online: 12 November 2019; doi:10.1038/d41586-019-03490-8The drug, which has already been given to hundreds of thousands of people in the Democratic Republic of the Congo, can now be distributed more widely.
Source: Nature AOP - Category: Research Authors: Source Type: research
Merck's Ervebo gets its first regulatory greenlight. A decision from the US Food and Drug Administration is expected in the next few months.
Source: The Scientist - Category: Science Tags: News & Opinion Source Type: news
U.S. drugmaker Merck&Co Inc on Monday received approval from the European Commission to market (http://bit.ly/2NZ0QMB) its Ebola vaccine, less than a month after a European medicines panel backed the first-ever vaccine against the deadly virus.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
[Malawi News Agency] Lilongwe -The Ministry of Health and Population has stressed the need for the country to stay prepared for Ebola disease even though there has been no single confirmed case registered in the country.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
More News: Belgium Health | Congo Health | Ebola | Health | Science